Real-world analysis of biomarker testing and use of targeted therapies in metastatic non-small cell lung cancer (mNSCLC) in the United States (US)

被引:0
|
作者
Dennis, Michael J.
Abrahami, Devin
Vieira, Maria Cecilia
Benjumea, Darrin
Boyd, Marley
Shao, Anran
Duncan, Kirsten
Kelton, John
Patel, Sandip P.
机构
关键词
D O I
10.1158/1538-7445.AM2024-2552
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2552
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Caveat emptor: A descriptive analysis of guideline-recommended biomarker inclusion in targeted NGS panels for metastatic non-small cell lung cancer (mNSCLC).
    Fox, John Leonard
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [42] Real-world BRAF testing patterns for patients with metastatic colorectal cancer (mCRC), metastatic melanoma, and non-small cell lung cancer (NSCLC).
    Edwards, Michelle L.
    Levin, Rebecca
    Abraham, Anup
    Amari, Diana T.
    Kelton, John M.
    Vieira, Maria Cecilia
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [43] Real-world ALK Testing Trends in Patients With Advanced Non-Small-Cell Lung Cancer in the United States
    Lin, Huamao M.
    Wu, Yanyu
    Yin, Yu
    Niu, Huifeng
    Curran, Eileen A.
    Lovly, Christine M.
    Humphries, Michael J.
    CLINICAL LUNG CANCER, 2023, 24 (01) : E39 - E49
  • [44] Trends in real-world biomarker testing and overall survival in US patients with advanced non-small-cell lung cancer
    Wu, Ning
    Ge, Wenzhen
    Quek, Ruben G. W.
    Gleeson, Michelle
    Pouliot, Jean-Francois
    Dietz, Hilary
    Jalbert, Jessica J.
    Harnett, James
    Antonia, Scott J.
    FUTURE ONCOLOGY, 2022, 18 (39) : 4385 - 4397
  • [45] Survival Trends in Histologic Subtypes of Metastatic Non-Small Cell Lung Cancer (mNSCLC) in the United States: 2000-2010
    Olszewski, A. J.
    Ali, S.
    Witherby, S. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S57 - S58
  • [46] Advances in Diagnosis and Treatment of Non-Small Cell Lung Cancer Are Translating into Real-World Survival Gains in the United States
    Akinboro, O.
    Nwabudike, S.
    Charlot, M.
    Acevedo, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S869 - S869
  • [47] Associations between biomarker testing and characteristics of patients with metastatic non-small cell lung cancer (mNSCLC): An analysis of CancerLinQ Discovery (CLQD) data.
    Mileham, Kathryn Finch
    Garrett-Mayer, Elizabeth
    Kaltenbaugh, Melinda
    Kirkwood, Margaret Kelsey
    Schenkel, Caroline
    Bruinooge, Suanna Steeby
    Osarogiagbon, Raymond U.
    Jalal, Shadia Ibrahim
    Moore, Amy
    Roy, Upal Kunal Basu
    Freeman-Daily, Janet
    Virani, Shamsuddin
    Garon, Edward B.
    Silvestri, Gerard A.
    Rosenthal, Lauren
    Smith, Robert A.
    Johnson, Bruce E.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [48] INCREASED REAL-WORLD BIOMARKER TEST UTILIZATION IN PATIENTS WITH EARLY-STAGE NON-SMALL CELL LUNG CANCER IN THE UNITED STATES, 2011 TO 2021
    Yan, J.
    Jin, Y.
    Lo, E.
    Chen, Y.
    Hanlon, Newell Ae
    Kong, Y.
    Inge, L.
    VALUE IN HEALTH, 2023, 26 (06) : S306 - S306
  • [49] Real-World Biomarker Testing and Treatment Patterns Identified Using Machine Learning in Early Non-small Cell Lung Cancer
    Lee, J. M.
    Schulze, K.
    Nedzesky, J.
    Ng, C.
    Ogale, S.
    Johnson, A.
    Hasan, H.
    Secrest, M. H.
    Cohen, A.
    Castellanos, E.
    Estola, E.
    Estevez, M.
    Lee, J. S.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S555 - S556
  • [50] Differences in Biomarker Testing in Non-Small Cell Lung Cancer (NSCLC): Real-World Experience Within an Integrated Healthcare System
    Alcasid, Nathan
    Sarovar, Varada
    Yang, Jingrong
    Sakoda, Lori
    Velotta, Jeffrey
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2024, 239 (05) : S484 - S484